Series A Archives - Page 2 of 2

Parker Institute CEO Jeffrey Bluestone Steps Down to Launch Sonoma Biotherapeutics

Appointments, Autoimmune Diseases, Business, Cell Therapy, Company Launches, Departures, Financing, Immunity, Immunotherapies, People on the Move, Series A, T-Cells

Jeffrey Bluestone, the noted scientific researcher and pioneer in understanding T-cell activation and immune tolerance in cancer patients, stepped down from his role as chief executive of the Parker Institute for Cancer Immunotherapy to launch Sonoma Biotherapeutics.

February 6, 2020/by BioSpace

Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing

Appointments, Business, Financing, Gene Therapy, Hearing Disorders, Monogenic Disorders, People on the Move, Series A

Akouos, a precision genetic medicine company developing gene therapies that restore and preserve hearing, today announced that the company raised $50 million in Series A financing.

August 7, 2018/by Business Wire